GO:0001522 pseudouridine synthesis: RNA Modification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001522 (pseudouridine synthesis) describes the intramolecular conversion of uridine to pseudouridine within an RNA molecule, also called pseudouridylation.
• Pseudouridine (Ψ) is the most abundant modified nucleotide in RNA and is introduced by pseudouridine synthases (PUS enzymes) across tRNA, rRNA, snRNA and mRNA.
• Pseudouridylation can alter RNA structure, stability, translation and immune recognition, making it central to RNA biology and therapeutics [2,3,5].
• Dysregulated pseudouridylation is linked to cancer, mitochondrial disease, erythropoiesis defects and renal protection pathways [6,7,8].
• Synthetic pseudouridine incorporation into mRNA reduces innate immune activation and enhances translational capacity, underpinning mRNA vaccine technology [2,3,5].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of PUS enzyme function in cells and animal models [4,8].
Description
Pseudouridine synthesis (GO:0001522) is the biological process in which a uridine residue within an RNA molecule is isomerized to pseudouridine (Ψ), the most abundant post-transcriptional RNA modification. This intramolecular conversion is catalyzed by pseudouridine synthases and occurs in diverse RNA species including tRNA, rRNA, snRNA and mRNA. The modification is not a simple chemical curiosity: it changes RNA base-pairing, local structure and protein interactions, thereby influencing translation, splicing and RNA stability [4,5]. Researchers study GO:0001522 because it sits at the intersection of RNA modification, gene regulation and human disease, and because pseudouridine itself has become a cornerstone of therapeutic mRNA design [2,3]. The same modification that fine-tunes endogenous RNA function can be deployed synthetically to evade innate immune sensors and boost protein output from mRNA therapeutics [2,3,5]. Understanding which enzymes write pseudouridine, on which RNAs, and with what consequences is therefore a high-priority research area.
pseudouridine synthesis At A Glance
| GO ID | GO:0001522 |
|---|---|
| GO term | pseudouridine synthesis |
| Ontology | biological_process |
| Synonym | pseudouridylation |
| Definition | The intramolecular conversion of uridine to pseudouridine within an RNA molecule. |
| Major function | Post-transcriptional isomerization of uridine to pseudouridine in tRNA, rRNA, snRNA and mRNA, affecting RNA structure, stability, translation and immune recognition. |
| Catalytic agents | Pseudouridine synthases (PUS enzymes) including PUS1, PUS7, PUS10, DKC1 and others [4,8]. |
| Substrate RNAs | tRNA, rRNA, snRNA, mRNA and mitochondrial transcripts [4,6,7]. |
| Disease relevance | Cancer, mitochondrial disease, erythropoiesis defects and renal protection [6,7,8]. |
What Is GO:0001522?
GO:0001522 pseudouridine synthesis is defined as the intramolecular conversion of uridine to pseudouridine within an RNA molecule. In plain terms, an enzyme rearranges the atoms of a uridine base already embedded in an RNA chain so that it becomes pseudouridine, without adding or removing nucleotides. The synonym pseudouridylation captures the same process.
Why Is pseudouridine synthesis Important in Cell Biology?
Pseudouridine synthesis matters because it is a reversible-looking but enzymatically controlled layer of RNA regulation that affects nearly every step of RNA life, from folding and splicing to translation and immune detection. Because pseudouridine strengthens base stacking and can alter hydrogen-bonding patterns, its presence can stabilize RNA structures and change how RNAs interact with proteins and sensors [4,5]. This has direct therapeutic implications: incorporating pseudouridine into synthetic mRNA suppresses innate immune activation and increases translational capacity, a finding that enabled modern mRNA therapeutics [2,3,5]. At the same time, misregulated pseudouridylation contributes to cancer progression and mitochondrial dysfunction, making PUS enzymes potential drug targets and biomarkers [6,8].
• Pseudouridine is the most abundant RNA modification and is essential for normal RNA function.
• Pseudouridylation influences translation efficiency and RNA stability [4,5].
• Pseudouridine incorporation reduces innate immune activation of mRNA, enabling therapeutic mRNA design [2,3].
• PUS1-mediated mRNA pseudouridylation promotes translation of oncogenic mRNAs in hepatocellular carcinoma.
• Mitochondrial tRNA pseudouridylation is required for normal erythropoiesis.
• Hypoxia-responsive tRNA-derived small RNAs and pseudouridylation contribute to renal protection via RNA autophagy.
• Dysregulated pseudouridylation is implicated in cancer, mitochondrial disease and other disorders [4,6,8].
• PUS enzymes are emerging targets for small-molecule and RNA-based therapeutics.
• CRISPR models allow causal testing of PUS gene function in disease contexts [4,8].
• Pseudouridine chemistry underpins next-generation mRNA vaccines and protein replacement therapies [2,3,5].
What Happens During pseudouridine synthesis?
Recognition of target uridine in RNA
In simple terms: The enzyme first finds the exact uridine it needs to modify inside a folded RNA molecule.
Pseudouridine synthases recognize their target uridines through a combination of sequence context and RNA structure, often within tRNA anticodon loops, rRNA helices or mRNA coding regions. Different PUS enzymes have distinct substrate preferences, which determines which RNAs and which positions are pseudouridylated. This recognition step is the primary determinant of specificity in GO:0001522.
Catalytic isomerization of uridine to pseudouridine
In simple terms: The enzyme rearranges the uridine base so it becomes pseudouridine, without breaking the RNA chain.
The catalytic core of pseudouridine synthases performs an intramolecular isomerization that converts the uridine base into pseudouridine while the ribose-phosphate backbone remains intact. This reaction changes the position of the glycosidic bond and introduces an extra hydrogen-bond donor, which can stabilize RNA structure. The reaction is the defining chemical event of GO:0001522.
Structural and functional consequences for the RNA
In simple terms: Once pseudouridine is installed, the RNA folds differently and interacts differently with proteins.
Pseudouridine can enhance base stacking and alter local RNA conformation, which in turn affects RNA-protein interactions, splicing and translation [4,5]. In mRNA, pseudouridylation can increase translational capacity and reduce activation of innate immune sensors such as PKR. These downstream effects explain why GO:0001522 is functionally important beyond the chemical modification itself [4,5].
Pseudouridine synthesis in tRNA and mitochondrial RNA
In simple terms: Pseudouridylation also happens in tRNA and mitochondrial RNAs, where it supports normal cellular functions.
Mitochondrial tRNA pseudouridylation is required for normal erythropoiesis, linking GO:0001522 to mitochondrial gene expression and blood cell development. Hypoxia-responsive tRNA-derived small RNAs and their pseudouridylation contribute to renal protection through RNA autophagy. These findings show that pseudouridine synthesis operates across multiple RNA compartments and physiological contexts [6,7].
Pseudouridine synthesis and immune recognition
In simple terms: Pseudouridine helps RNA avoid being detected by the immune system.
Pseudouridine-containing RNA avoids immune detection through impaired endolysosomal processing and reduced TLR engagement. Incorporation of pseudouridine into mRNA yields a superior nonimmunogenic vector with increased translational capacity and biological stability. These properties make GO:0001522 mechanistically relevant to RNA therapeutics and vaccine design [2,3].
Key Genes Involved in GO:0001522 pseudouridine synthesis
The genes below encode pseudouridine synthases and related factors that catalyze or regulate pseudouridine synthesis (GO:0001522) in human cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PUS1 | Pseudouridine synthase that modifies tRNA and mRNA | Promotes hepatocellular carcinoma through mRNA pseudouridylation and enhanced translation of oncogenic mRNAs |
| PUS7 | Pseudouridine synthase acting on tRNA and other RNAs | Implicated in RNA modification-dependent regulation of translation and stem cell function |
| PUS10 | Pseudouridine synthase with roles in tRNA and other RNAs | Studied for its contribution to RNA modification landscapes and disease |
| DKC1 | Component of the H/ACA ribonucleoprotein complex that guides pseudouridylation | Linked to ribosomopathies and telomere maintenance through pseudouridylation |
| NOP10 | H/ACA RNP component required for pseudouridylation | Supports guide RNA-dependent pseudouridine synthesis |
| NHP2 | H/ACA RNP component required for pseudouridylation | Essential for rRNA and snRNA pseudouridylation |
| GAR1 | H/ACA RNP component required for pseudouridylation | Facilitates pseudouridine synthase activity in the H/ACA complex |
| TRUB1 | Pseudouridine synthase acting on mRNA and other RNAs | Studied for mRNA pseudouridylation and translational control |
| PUS3 | Pseudouridine synthase modifying tRNA | Contributes to tRNA stability and translation fidelity |
| PUS4 | Pseudouridine synthase modifying tRNA | Model enzyme for mechanistic studies of pseudouridylation |
| PUS7L | Pseudouridine synthase-like protein | Potential regulator of RNA modification in specific tissues |
| RPUSD1 | Pseudouridine synthase acting on mitochondrial and nuclear RNAs | Linked to mitochondrial RNA modification |
| RPUSD2 | Pseudouridine synthase acting on mitochondrial and nuclear RNAs | Linked to mitochondrial RNA modification |
| RPUSD3 | Pseudouridine synthase acting on mitochondrial RNAs | Studied in mitochondrial gene expression |
| RPUSD4 | Pseudouridine synthase acting on mitochondrial RNAs | Studied in mitochondrial gene expression |
| PUSL1 | Pseudouridine synthase-like protein | Candidate RNA modification enzyme under investigation |
How Is pseudouridine synthesis Regulated?
Pseudouridine synthesis is regulated at multiple levels, including expression of PUS enzymes, availability of guide RNAs in H/ACA ribonucleoprotein complexes, and substrate RNA accessibility. Cellular stress such as hypoxia can induce tRNA-derived small RNAs that influence RNA autophagy and pseudouridylation-dependent protection. In cancer, PUS1 expression promotes mRNA pseudouridylation and enhances translation of oncogenic mRNAs, indicating that pseudouridylation can be co-opted by malignant cells. Mitochondrial tRNA pseudouridylation is required for erythropoiesis, showing that regulation of GO:0001522 is tissue- and context-dependent.
pseudouridine synthesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PUS1 | Hepatocellular carcinoma | PUS1 knockout and overexpression in liver cancer cell lines |
| PUS1 | Mitochondrial tRNA pseudouridylation and erythropoiesis | PUS1 knockout hematopoietic models |
| DKC1 | Ribosomopathy and telomere maintenance | DKC1 point-mutation knock-in cell models |
| PUS7 | RNA modification-dependent translation and stem cell function | PUS7 knockout and rescue models |
| TRUB1 | mRNA pseudouridylation and translational control | TRUB1 knockout and tagged knock-in models |
Pseudouridylation in cancer
PUS1 promotes hepatocellular carcinoma through mRNA pseudouridylation that enhances translation of oncogenic mRNAs, linking GO:0001522 to tumor progression. Broader reviews highlight pseudouridylation as a contributor to cancer biology and a potential therapeutic target.
Pseudouridylation in mitochondrial disease and erythropoiesis
Mitochondrial tRNA pseudouridylation governs erythropoiesis, and defects in this process can impair red blood cell development. This connects GO:0001522 to mitochondrial gene expression disorders and hematological phenotypes.
Pseudouridylation in renal protection and stress responses
A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy, implicating pseudouridylation-related pathways in kidney stress responses. This suggests that GO:0001522 can be protective in specific physiological contexts.
Pseudouridylation and immune recognition
Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement, which is relevant to autoimmune and inflammatory responses to RNA. This mechanism also underpins the reduced immunogenicity of pseudouridine-containing mRNA therapeutics [2,3].
From pseudouridine synthesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PUS1 affect oncogenic mRNA translation? | PUS1 knockout cancer cell line |
| Does a specific PUS catalytic residue drive pseudouridylation? | Point-mutation knock-in of catalytic residue |
| Can pseudouridylation of a target mRNA be tracked in live cells? | Tagged knock-in of PUS enzyme |
| Does PUS1 overexpression promote tumor growth? | PUS1 overexpression cell line and xenograft |
| Does mitochondrial tRNA pseudouridylation affect erythropoiesis? | PUS1 knockout hematopoietic model |
| Does pseudouridine incorporation alter immune sensing? | Pseudouridine-modified mRNA transfection in immune cells [2,3] |
How to Study the pseudouridine synthesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pseudouridine mapping (Psi-seq) | Transcriptome-wide pseudouridine sites | Identifying target RNAs of PUS enzymes |
| Ribo-seq | Translation efficiency and ribosome occupancy | Testing effects of pseudouridylation on translation [5,8] |
| Polysome profiling | mRNA loading onto ribosomes | Assessing translational capacity of modified mRNAs |
| Cytokine induction assay | Innate immune activation | Evaluating immunogenicity of pseudouridine-containing RNA [2,3] |
| TLR activation assay | TLR engagement by RNA | Testing immune evasion of pseudouridylated RNA |
| CRISPR knockout screening | Gene requirement for phenotypes | Identifying PUS genes involved in disease [4,8] |
| CRISPR knock-in tagging | Protein localization and interactions | Tracking PUS enzymes in cells |
| RNA immunoprecipitation | RNA-protein interactions | Mapping PUS enzyme binding to target RNAs |
RNA sequencing and pseudouridine mapping
Pseudouridine mapping methods such as Psi-seq and related chemical approaches identify pseudouridylated sites transcriptome-wide, enabling researchers to link GO:0001522 to specific RNAs. These methods are essential for defining which transcripts are modified under different conditions.
Ribosome profiling and translation assays
Ribo-seq and polysome profiling measure translation efficiency of pseudouridylated mRNAs, helping to test whether pseudouridylation enhances translation of oncogenic or therapeutic mRNAs [5,8]. These assays connect GO:0001522 to protein output [5,8].
Immune activation assays
Cytokine induction and TLR activation assays assess whether pseudouridine-containing RNA avoids innate immune detection, a key property of pseudouridine-modified mRNA [2,3]. These assays are used to evaluate therapeutic mRNA design [2,3].
CRISPR-based functional genomics
CRISPR knockout and knock-in screens can systematically test the role of PUS enzymes and related factors in RNA modification, translation and disease phenotypes [4,8]. Such screens link genotype to pseudouridylation-dependent phenotypes [4,8].
How CRISPR Can Be Used to Study GO:0001522 pseudouridine synthesis
Knockout
CRISPR knockout of PUS genes such as PUS1, PUS7 or DKC1 eliminates pseudouridylation at specific sites, allowing researchers to test loss-of-function phenotypes in cancer, mitochondrial and immune models [4,8]. Knockout models are foundational for establishing causality in GO:0001522 research [4,8].
Point Mutation
Point-mutation knock-in of catalytic residues in pseudouridine synthases can separate enzymatic activity from scaffolding functions, providing precise mechanistic insight into GO:0001522. Such models are valuable when complete knockout causes pleiotropic effects.
Knock-in
Tagged knock-in of PUS enzymes enables live-cell imaging, immunoprecipitation and proteomic analysis of pseudouridylation complexes. Knock-in of disease-associated variants can model human mutations linked to pseudouridylation disorders.
Overexpression
Overexpression of PUS1 or other pseudouridine synthases can drive increased mRNA pseudouridylation and enhanced translation of oncogenic mRNAs, modeling gain-of-function disease states. Overexpression models are also used to study therapeutic mRNA modification [2,3].
How EDITGENE Supports pseudouridine synthesis Research
Researchers studying pseudouridine synthesis-related genes often need to determine whether a candidate gene is causally involved in RNA modification, translation control or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services that enable precise, reproducible interrogation of GO:0001522 and its associated enzymes.
Contact EDITGENE today to design your custom CRISPR model for pseudouridine synthesis research.
Frequently Asked Questions About pseudouridine synthesis
What is pseudouridine synthesis?
Pseudouridine synthesis (GO:0001522) is the intramolecular conversion of uridine to pseudouridine within an RNA molecule, also called pseudouridylation.
What genes are involved in pseudouridine synthesis?
Key genes include PUS1, PUS7, PUS10, DKC1, NOP10, NHP2, GAR1, TRUB1 and RPUSD family members, which encode pseudouridine synthases and H/ACA complex components [4,8].
Why is pseudouridine important in mRNA therapeutics?
Incorporating pseudouridine into mRNA yields a superior nonimmunogenic vector with increased translational capacity and biological stability.
How does pseudouridine avoid immune detection?
Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and reduced TLR engagement.
Does pseudouridylation affect translation?
Yes, incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.
Is pseudouridylation linked to cancer?
PUS1 promotes hepatocellular carcinoma through mRNA pseudouridylation to enhance translation of oncogenic mRNAs.
What is the role of mitochondrial tRNA pseudouridylation?
Mitochondrial tRNA pseudouridylation governs erythropoiesis, linking it to red blood cell development.
Can pseudouridylation protect the kidney?
A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy, implicating pseudouridylation-related pathways.
How can I study pseudouridine synthesis with CRISPR?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of PUS gene function in disease and RNA biology [4,8].
What methods map pseudouridine sites?
Pseudouridine mapping methods such as Psi-seq identify pseudouridylated sites transcriptome-wide, and Ribo-seq measures their impact on translation [4,5].
Conclusion
Pseudouridine synthesis (GO:0001522) is a fundamental RNA modification process that shapes RNA structure, translation and immune recognition. Its importance spans cancer, mitochondrial biology, erythropoiesis and therapeutic mRNA design, with PUS enzymes and H/ACA complex components as key molecular players [2,3,6,8]. CRISPR-based models and modern RNA mapping methods now make it feasible to dissect the causal roles of individual pseudouridine synthases in health and disease [4,8].
References
- 2. Karikó K et al.. 2008. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.. Mol Ther 16(11):1833-40 PMID: 18797453
- 3. Bérouti M et al.. 2025. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement.. Cell 188(18):4880-4895.e15 PMID: 40580950
- 4. Luo N et al.. 2025. Functions and therapeutic applications of pseudouridylation.. Nat Rev Mol Cell Biol 26(9):691-705 PMID: 40394244
- 5. Anderson BR et al.. 2010. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.. Nucleic Acids Res 38(17):5884-92 PMID: 20457754
- 6. Wang B et al.. 2024. Mitochondrial tRNA pseudouridylation governs erythropoiesis.. Blood 144(6):657-671 PMID: 38635773
- 7. Li G et al.. 2025. A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy.. Science 389(6763):eadp5384 PMID: 40674449
- 8. Hu YX et al.. 2024. Pseudouridine synthase 1 promotes hepatocellular carcinoma through mRNA pseudouridylation to enhance the translation of oncogenic mRNAs.. Hepatology 80(5):1058-1073 PMID: 38015993
